Daily MailCould artificial blood soon be on tap? Scientists crack the code for making an unlimited supply using immortal stem …Daily MailArtificial blood grown in the lab could one day be available on tap thanks to a new scientific breakthrough. Rese… Continue reading
|
Incysus Announces Preclinical Data Presentations of γδ T Cell Immunotherapy Programs at Upcoming Medical …
GlobeNewswire (press release) The research conducted at UAB provides a demonstration of the mechanisms related to a Drug Resistant Immunotherapy (DRI) using activated γδ T cells for treating cancer. Incysus and UAB are moving quickly towards an investigational new drug application … |
TrendinTech |
Doctors Use Gene-Edited Immune Cells to Treat Leukemia Patients
TrendinTech What makes this study particularly exciting is that uses a combination of CAR T cell therapy and a new gene-editing technique called TALENS to free the patient from the disease. It’s not the first time CAR T’s been used as part of an immunotherapy … |
OncLive |
CRISPR Builds More Powerful CAR T Cells
OncLive Senior author Michel Sadelain, MD, PhD, and fellow researchers at his lab at Memorial Sloan Kettering Cancer Center, have recently published evidence to show that this CRISPR technology can deliver the synthetic receptor CAR to the TRAC locus in the … CRISPR Gene-Editing: Moving Outside Our Bodies and Into the WorldBU News Service CRISPR/Cas9 Reveals Cancer’s Synthetic Lethal VulnerabilitiesNext Big Future |
OncLive |
CRISPR Builds More Powerful CAR T Cells
OncLive Senior author Michel Sadelain, MD, PhD, and fellow researchers at his lab at Memorial Sloan Kettering Cancer Center, have recently published evidence to show that this CRISPR technology can deliver the synthetic receptor CAR to the TRAC locus in the … CRISPR Gene-Editing: Moving Outside Our Bodies and Into the WorldBU News Service CRISPR/Cas9 Reveals Cancer’s Synthetic Lethal VulnerabilitiesNext Big Future |
Bend Bulletin |
Stem cell transplant reduces Culver woman’s MS symptoms
Bend Bulletin Three years after undergoing stem cell transplants, disability symptoms in nearly 80 percent of the patients had not worsened, according to the study, published in the in the Journal of the American Medical Association Neurology. At five years, nearly … |